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The small heat shock proteins (sHSPs), HSP25/27 and
alpha B-crystallin, are more prominent in glia than in neu-
rons, act as molecular chaperones and specifically interact
with cytoskeletal elements. They represent prominent
constituents in inclusion bodies originating in astrocytes
and oligodendrocytes, and have been described to be
involved in Alexander's disease, a human neurodegenera-
tive disorder with astrocytic inclusions called Rosenthal
fibres (RF). These protein aggregates also contain GFAP
(glial fibrillary acidic protein) and ubiquitin, indicating
that inclusion body formation might be causally related
to an impairment of the ubiquitin proteasome pathway
(UPS).
In the present study, we have examined if defects in the
UPS system contribute to the protein aggregation process
in astrocytes. Cultured astrocytes, prepared from the
brains of newborn rats, were treated with the proteasomal
inhibitor MG-132 (5 μM). Under control conditions,
astrocytes constitutively express high levels of HSP25, but
only very low amounts of alpha B-crystallin. Treatment
with MG-132 for 24 h caused the upregulation of HSP25
and alpha B-crystallin, which both were increasingly
found in the detergent insoluble fraction. Indirect
immunofluorescence analysis displayed small aggregates
of HSP25 throughout the cytoplasm and in the perinu-
clear region. These aggregates also contained alpha B-crys-
tallin and ubiquitin. Furthermore, the disassembly of the
microfilament system was observable, while GFAP inter-
mediate filaments and microtubules remained largely
intact, and only disassembled at later times of treatment
(48 h). The effects of MG-132 were reversible and did not
cause apoptotic cell death, as observed in oligodendro-
cytes. After 24 h in the absence of MG-132, the cytoskele-
ton was reorganized and the protein aggregates were
almost completely removed, and HSP25 was diffusely
present and alpha B-crystallin remained in small aggre-
gates throughout the cytoplasm.
Hence, proteasomal inhibition leads to HSP induction
and the formation of inclusion bodies, as observed in
neurodegenerative diseases. In astrocytes these aggregates
are not toxic, and their formation might be a rescue mech-
anism to protect cells from unwanted interactions with
amyloid proteins.
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